DUE: December 31, 2023
Seeking pharmaceutical innovations for treatment of hemorrhagic shock in humans in a pre-hospital setting.
Anti-Shock Drug, Pre-Hospital (ASD-PH)
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.